Regenxbio (RGNX) EBITDA (2015 - 2025)
Regenxbio's EBITDA was -$53.77 million in Q4 2025, compared with -$47.35 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) EBITDA (2015 - 2025) Analysis & Trends
For FY2025, EBITDA at Regenxbio came in at -$145.58 million.
- In earlier years, EBITDA was -$217.13 million in FY2024, -$250.81 million in FY2023, -$249.97 million in FY2022 and $169.58 million in FY2021.
- Quarterly EBITDA has moved between -$68.94 million (Q1 2022) and $316.24 million (Q4 2021) over five years.
- Per Business Quant data, RGNX's EBITDA in the three quarters before Q4 2025 was -$48.53 million (Q3 2025), -$59.37 million (Q2 2025) and $16.08 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Regenxbio | 404.61 Mn | -528.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -53.77 Mn |
| Sep 30, 2025 | -48.53 Mn |
| Jun 30, 2025 | -59.37 Mn |
| Mar 31, 2025 | 16.08 Mn |
| Dec 31, 2024 | -47.35 Mn |
| Sep 30, 2024 | -58.12 Mn |
| Jun 30, 2024 | -51.99 Mn |
| Mar 31, 2024 | -59.68 Mn |
| Dec 31, 2023 | -59.57 Mn |
| Sep 30, 2023 | -60.59 Mn |
| Jun 30, 2023 | -68.67 Mn |
| Mar 31, 2023 | -61.98 Mn |
| Dec 31, 2022 | -53.65 Mn |
| Sep 30, 2022 | -67.50 Mn |
| Jun 30, 2022 | -59.89 Mn |
| Mar 31, 2022 | -68.94 Mn |
| Dec 31, 2021 | 316.24 Mn |
| Sep 30, 2021 | -54.52 Mn |
| Jun 30, 2021 | -50.03 Mn |
| Mar 31, 2021 | -42.11 Mn |
API Access
Regenxbio EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();